pirenzepine has been researched along with Coronary Disease in 1 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Olanzapine is an antipsychotic drug that has been on the market since 1996." | 1.31 | Overdose and death with olanzapine: two case reports. ( Cawthon, B; Gerber, JE, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gerber, JE | 1 |
| Cawthon, B | 1 |
1 other study available for pirenzepine and Coronary Disease
| Article | Year |
|---|---|
Overdose and death with olanzapine: two case reports.
Topics: Adult; Antipsychotic Agents; Autopsy; Benzodiazepines; Coronary Disease; Drug Overdose; Fatal Outcom | 2000 |